Emergency contraception. Widely available and effective but disappointing as a public health intervention: a review
Author(s) -
ESHRE Capri Workshop Group,
David T. Baird,
Sharon Cameron,
J.L.H. Evers,
Kristina GemzellDanielsson,
Anna Glasier,
Caroline Moreau,
James Trussell,
Helena von Hertzen,
Carlo La Vecchia,
Annibale Volpe
Publication year - 2015
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/dev019
Subject(s) - emergency contraception , levonorgestrel , medicine , unintended pregnancy , pregnancy , family planning , ovulation , public health , gynecology , obstetrics , developed country , clinical trial , intensive care medicine , population , environmental health , research methodology , nursing , biology , hormone , genetics
Emergency contraception (EC) prevents pregnancy after unprotected sex or contraceptive failure. Use of EC has increased markedly in countries where a product is available over the counter, yet barriers to availability and use remain. Although effective in clinical trials, it has not yet been possible to show a public health benefit of EC in terms of reduction of unintended pregnancy rates. Selective progesterone receptor modulators developed as emergency contraceptives offer better effectiveness than levonorgestrel, but still EC is less effective than use of ongoing regular contraception. Methods which inhibit ovulation whenever they are taken or which act after ovulation to prevent implantation and strategies to increase the uptake of effective ongoing contraception after EC use would prevent more pregnancies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom